Clinical Trial: A prospective, single-arm, multicenter clinical study of lisaftoclax combined with azacitidine in the treatment of chronic myelomonocytic leukemia (CMML). (China)

China, Sept. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, single-arm, multicenter clinical study of lisaftoclax combined with azacitidine in the treatment of chronic myelomonocytic leukemia (CMML).'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133250

Registration Time: 2026/09/23

Type: Interventional study

Primary Sponsor: Zhenjiang First People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344674

Published by HT Digital Content Services with permission from Health Daily Digest....